PO.MCB11.01 · 分子与细胞生物学
翻译重编程破坏有丝分裂以驱动SMAD4缺陷型食管腺癌
Translational reprogramming disrupts mitosis to drive SMAD4-deficient esophageal adenocarcinoma
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
食管腺癌(EAC)由一种名为Barrett食管的前驱病变发展而来;这一进展可通过日益增加的基因组不稳定性来追踪。我们此前已表明,在已存在TP53突变的Barrett食管细胞中,SMAD4缺失诱导肿瘤发生和拷贝数改变(CNA)增加。所观察到的CNA增加在由此产生的SMAD4缺陷型肿瘤细胞中尤为明显,提示这些细胞在其致癌进展过程中发生了有丝分裂错误的积累。然而,这种效应无法用我们目前对经典SMAD4信号的理解来解释。因此,在本研究中,我们旨在阐明SMAD4在维持EAC染色体稳定性中的作用。我们的多组学(RNA测序、蛋白质组学和反相蛋白阵列)方法在SMAD4缺陷型细胞中检测到翻译和有丝分裂两种失调特征。使用活细胞成像,我们证明TP53突变的SMAD4缺陷型细胞比仅有TP53突变的细胞表现出显著更多的有丝分裂错误,尤其是染色体分离缺陷,这些缺陷常导致染色体不稳定性(CIN)。与此一致,对TCGA数据的分析表明,CIN在同时具有SMAD4和TP53突变的肿瘤中比单独任一突变的肿瘤中更为普遍。进一步的生化分析揭示,这些细胞中帽依赖性翻译增加,而内部核糖体进入位点(IRES)介导的翻译减少。IRES介导的翻译对于许多重要有丝分裂蛋白的合成至关重要,包括一种细胞周期激酶的有丝分裂特异性异构体。多聚核糖体测序显示,SMAD4缺陷型细胞中这种激酶的翻译(而非转录)减少。异位表达该激酶的有丝分裂特异性异构体挽救了因SMAD4缺失而产生的有丝分裂错误。总之,我们提出一个模型,其中翻译重编程破坏有丝分裂,诱导CIN并可能在SMAD4缺失的情况下驱动EAC肿瘤发生。这代表了EAC中一种新的肿瘤发生机制,以及SMAD4在维持染色体完整性中此前未知的作用。
查看英文原文 English abstract
Esophageal adenocarcinoma (EAC) develops from a precursor lesion named Barrett's esophagus; a progression that can be mapped by increasing genomic instability. We have previously shown that SMAD4 loss induces tumorigenesis and increased copy number alterations (CNA) in Barrett's esophagus cells with an existing TP53 mutation. The observed CNA increase was especially pronounced in the resultant SMAD4-deficient tumor cells, suggesting that accumulation of mitotic errors occurs in these cells throughout their oncogenic progression. However, such an effect cannot be explained by our current understanding of canonical SMAD4 signalling. Thus, in this study, we aimed to delineate the role of SMAD4 in maintaining chromosomal stability in EAC. Our multi-omics (RNA-sequencing, proteomics and reverse-phase protein array) approach detected both deregulated translation and mitosis signatures in SMAD4-deficient cells. Using live cell imaging, we demonstrated that TP53 -mutant SMAD4-deficient cells exhibit significantly more mitotic errors than TP53 -mutant only cells, particularly chromosome segregation defects, which frequently result in chromosomal instability (CIN). Consistent with this, analysis of TCGA data demonstrated that CIN was more prevalent in tumours with both SMAD4 and TP53 mutation than either mutation alone. Further biochemical analyses revealed an increase in cap-dependent translation in these cells, and a decrease in internal ribosome entry site (IRES)-mediated translation. IRES-mediated translation is essential for synthesis of many important mitotic proteins, including a mitosis-specific isoform of a cell cycle kinase. Polysome sequencing showed decreased translation (but not transcription) of this kinase in SMAD4-deficient cells. Ectopic expression of mitosis-specific isoform of this kinase rescued the mitotic errors that arose as a consequence of SMAD4 loss. In sum, we present a model where translational reprogramming disrupts mitosis, inducing CIN and potentially driving EAC tumorigenesis in response to loss of SMAD4. This represents a novel mechanism of tumorigenesis in EAC and a previously unknown role of SMAD4 in maintaining chromosomal integrity.
利益披露 Disclosure
J. V. Milne,
Astex Pharmaceuticals, UK ).
K. Wu, None..
S. Witts, None..
E. Kusnadi, None..
K. Fujihara, None..
K. Papastratos, None..
M. Pechlivanis, None..
A. Trigos, None..
M. Jana, None..
L. Furic, None..
K. Simpson, None..
D. Liu, None..
C. Duong, None..
W. Phillips, None.
N. Clemons,
Astex Pharmaceuticals, UK ).